Polpharma Biologics and MS Pharma partner to expand biosimilar access
Written by
PharmaTimes
Published
0
comments
0
min
Deal covers biosimilars for gastroenterology, neurology and dermatology Deal covers biosimilars for gastroenterology, neurology and dermatology